Considering that the mode of cell death influences the anti-tumor immune response and since DVL2 affects cell growth, further investigation is required to determine the mechanism by which shDVL2 enhances Neratinib in mediating cell death and its influence on the immunogenicity. Here, DVL2 is linked to neoplasm.